Effect of SLC7A11 Gene on Progression of Hepatocellular Carcinoma by Regualating  Iron Death Pathway

Liuzheng LI; Leisheng XU; Kanghong LUO; Mingting ZHANG; Yan WANG; Xuechang GAO; Jiawei FENG; Guocha GONG

doi:10.12259/j.issn.2095-610X.S20251004

Volume 46 Issue 10

Oct. 2025

Turn off MathJax

Article Contents

Article Navigation > Journal of Kunming Medical University > 2025 > 46(10): 32-43

Liuzheng LI, Leisheng XU, Kanghong LUO, Mingting ZHANG, Yan WANG, Xuechang GAO, Jiawei FENG, Guocha GONG. Effect of SLC7A11 Gene on Progression of Hepatocellular Carcinoma by Regualating Iron Death Pathway[J]. Journal of Kunming Medical University, 2025, 46(10): 32-43. doi: 10.12259/j.issn.2095-610X.S20251004

Citation:

Liuzheng LI, Leisheng XU, Kanghong LUO, Mingting ZHANG, Yan WANG, Xuechang GAO, Jiawei FENG, Guocha GONG. Effect of SLC7A11 Gene on Progression of Hepatocellular Carcinoma by Regualating Iron Death Pathway[J]. Journal of Kunming Medical University, 2025, 46(10): 32-43. doi: 10.12259/j.issn.2095-610X.S20251004

Citation:

Liuzheng LI, Leisheng XU, Kanghong LUO, Mingting ZHANG, Yan WANG, Xuechang GAO, Jiawei FENG, Guocha GONG. Effect of SLC7A11 Gene on Progression of Hepatocellular Carcinoma by Regualating Iron Death Pathway[J]. Journal of Kunming Medical University, 2025, 46(10): 32-43. doi: 10.12259/j.issn.2095-610X.S20251004

PDF( 8041 KB)

Effect of SLC7A11 Gene on Progression of Hepatocellular Carcinoma by Regualating Iron Death Pathway

doi: 10.12259/j.issn.2095-610X.S20251004

Department of Hepatobiliary Surgery，Lincang People’s Hospital，Lincang Yunnan 677000，China

Received Date: 2025-02-27
Publish Date: 2025-10-28

Abstract

Abstract

Objective To investigate the mechanism by which the SLC7A11 gene regulates the development and progression of hepatocellular carcinoma （HCCLM3） through the ferroptosis pathway, and to evaluate its potential as a therapeutic target. Methods Differentially expressed ferroptosis-related genes in liver cancer were screened based on data from the TCGA and ICGC databases. Detection of mRNA expression levels of TERT, MIOX, MYCN, NOX4, and SLC7A11 in tumor and adjacent non-tumorous tissues from 32 clinical liver cancer samples using qRT-PCR. Further analysis of SLC7A11 and its downstream molecules SLC3A2, GSS, and GPX4 was performed through qRT-PCR, Western blot, and IHC to assess expression levels and tissue distribution. A stable SLC7A11-knockdown HCCLM3 cell line was constructed and used to establish a subcutaneous xenograft tumor model in nude mice to evaluate its effect on tumor growth. Mice were divided into two groups （n = 6 per group）: HCCLM3 + sh-NC and HCCLM3 + sh-SLC7A11. Serum levels of IL-6, IL-1β, and TNF-α were measured using ELISA. Histopathological changes in tumor tissues were examined by H&E staining, and the expression of key genes was validated through multiple approaches. Results Bioinformatics analysis showed high expression of SLC7A11 in hepatocellular carcinoma tissues （P < 0.05）, significantly associated with poor patient prognosis. Clinical sample validation revealed significantly higher expression of SLC7A11, SLC3A2, GSS, and GPX4 in cancer tissues compared to control groups （All P < 0.05）. SLC7A11 knockdown significantly inhibited tumor volume and wet weight （P < 0.05）, and H&E staining showed reduced vascular density in the sh-SLC7A11 group. ELISA results showed elevated serum levels of IL-1β, IL-6, and TNF-α in the sh-SLC7A11 group. qRT-PCR, Western blot, and IHC all showed significantly downregulated expression of SLC7A11, SLC3A2, GSS, and GPX4 in tumor tissues （All P < 0.05）. Conclusion SLC7A11 inhibits ferroptosis by regulating the GSH-GPX4 axis, promoting hepatocellular carcinoma cell growth. Targeted inhibition of SLC7A11 can induce tumor cell ferroptosis and suppress tumor progression, suggesting it may be an important therapeutic target for hepatocellular carcinoma.
- SLC7A11,
- Gene,
- Ferroptosis,
- Hepatocellular carcinoma

FullText(HTML)

References(37)

References

[1]	Siegel R L , Miller K D , Wagle N S , et al. Cancer statistics, 2023[J]. CA: A Cancer Journal for Clinicians, 2023, 73(1): 17-48.
[2]	Filho A M , Laversanne M , Ferlay J , et al. The GLOBOCAN 2022 cancer estimates: Data sources, methods, and a snapshot of the cancer burden worldwide[J]. International Journal of Cancer, 2025, 156(7): 1336-1346.
[3]	徐若翔, 曾智明, 朱广志, 等. 肝细胞癌AASLD(2023年版)、NCCN(2024年版)、ASCO(2024年版)指南和中国《原发性肝癌诊疗指南(2024年版)》更新解读[J]. 中国普外基础与临床杂志, 2025, 32(2): 184-191.
[4]	Lin W, Wang C, Liu G, et al. SLC7A11/xCT in cancer: Biological functions and therapeutic implications[J]. Am J Cancer Res, 2020, 10(10): 3106-3126.
[5]	刘晓轩, 张驰, 黄思琪, 等. SLC7A11的调控机制及肿瘤治疗应用研究进展[J]. 中国肿瘤, 2023, 32(11): 878-885. doi: 10.11735/j.issn.1004-0242.2023.11.A010
[6]	Koppula P, Zhang Y, Zhuang L, et al. Amino acid transporter SLC7A11/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancer[J]. Cancer Commun(Lond), 2018, 38(1): 12.
[7]	Liu M R, Zhu W T, Pei D S. System Xc-: A key regulatory target of ferroptosis in cancer[J]. Invest New Drugs, 2021, 39(4): 1123-1131. doi: 10.1007/s10637-021-01070-0
[8]	Gong D, Chen M, Wang Y, et al. Role of ferroptosis on tumor progression and immunotherapy[J]. Cell Death Discov, 2022, 8(1): 427. doi: 10.1038/s41420-022-01218-8
[9]	Mukhopadhyay S, Biancur D E, Parker S J, et al. Autophagy is required for proper cysteine homeostasis in pancreatic cancer through regulation of SLC7A11[J]. Proc Natl Acad Sci USA, 2021, 118(6): e2021475118. doi: 10.1073/pnas.2021475118
[10]	Liu X, Nie L, Zhang Y, et al. Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis[J]. Nat Cell Biol, 2023, 25(3): 404-414.
[11]	吴伟刚, 田圆, 刘琢冰, 等. SLC7A11基因表达沉默的肝癌细胞株的构建及筛选[J]. 现代肿瘤医学, 2015, 23(2): 149-152. doi: 10.3969/j.issn.1672-4992.2015.02.02
[12]	Liu Y, Ouyang L, Mao C, et al. PCDHB14 promotes ferroptosis and is a novel tumor suppressor in hepatocellular carcinoma[J]. Oncogene, 2022, 41(27): 3570-3583. doi: 10.1038/s41388-022-02370-2
[13]	Yang J , Hu B , Zhang G , et al. Protocadherin 17 weakens the lenvatinib resistance of liver cancer through inducing ferroptosis[J]. Experimental Cell Research, 2025, 447(1): 114495.
[14]	Zhang B , Bao W , Zhang S , et al. LncRNA HEPFAL accelerates ferroptosis in hepatocellular carcinoma by regulating SLC7A11 ubiquitination[J]. Cell Death Dis, 2022, 13(8): 734.
[15]	Xie Y , Kang R , Klionsky D J , et al. GPX4 in cell death, autophagy, and disease[J]. Autophagy, 2023, 19(10): 2621-2638.
[16]	Reem A , Jos V D V , Nicholas H , et al. Glutaredoxin attenuates glutathione levels via deglutathionylation of Otub1 and subsequent destabilization of system xC [J]. Science Advances, 2023, 9(37): eadi5192.
[17]	Bi F , Qiu Y , Wu Z , et al. METTL9-SLC7A11 axis promotes hepatocellular carcinoma progression through ferroptosis inhibition[J]. Cell Death Discovery, 2023, 9(1): 428.
[18]	Zhang Y , Yao R , Li M , et al. CircTTC13 promotes sorafenib resistance in hepatocellular carcinoma through the inhibition of ferroptosis by targeting the miR-513a-5p/SLC7A11 axis[J]. Molecular Cancer, 2025, 24(1): 32.
[19]	Gnanapradeepan K , Basu S , Barnoud T , et al. The p53 tumor suppressor in the control of metabolism and ferroptosis[J]. Frontiers in Endocrinology, 2018, 9: 124.
[20]	Parkin D M , Bray M F , Ferlay M J , et al. Global cancer statistics, 2002[J]. Ca A Cancer Journal for Clinicians, 2005, 55(2): 74-108.
[21]	Tang W, Chen Z, Zhang W, et al. The mechanisms of sorafenib resistance in hepatocellular carcinoma: Theoretical basis and therapeutic aspects[J]. Signal Transduct Target Ther, 2020, 5(1): 87. doi: 10.1038/s41392-020-0187-x
[22]	Lei G, Zhuang L, Gan B. Targeting ferroptosis as a vulnerability in cancer[J]. Nat Rev Cancer, 2022, 22(7): 381-396. doi: 10.1038/s41568-022-00459-0
[23]	Li J, Cao F, Yin H L, et al. Ferroptosis: Past, present and future[J]. Cell Death Dis, 2020, 11(2): 88. doi: 10.1038/s41419-020-2298-2
[24]	Xu S, He Y, Lin L, et al. The emerging role of ferroptosis in intestinal disease[J]. Cell Death Dis, 2021, 12(4): 289. doi: 10.1038/s41419-021-03559-1
[25]	Jiang X, Stockwell B R, Conrad M. Ferroptosis: Mechanisms, biology and role in disease[J]. Nat Rev Mol Cell Biol, 2021, 22(4): 266-282. doi: 10.1038/s41580-020-00324-8
[26]	Lindblad K E , Donne R , Liebling I , et al. NOTCH1 drives sexually dimorphic immune responses in hepatocellular carcinoma[J]. Cancer Discov, 2025, 15(3): 495-510.
[27]	曾丹宁. 表达下调的FPN1通过调节SLC7A11和GPX4介导的铁死亡来抑制肝细胞癌的生长[D]. 广州: 广州医科大学, 2021.
[28]	Du A, Li S, Zhou Y, et al. M6A-mediated upregulation of circMDK promotes tumorigenesis and acts as a nanotherapeutic target in hepatocellular carcinoma[J]. Mol Cancer, 2022, 21(1): 109. doi: 10.1186/s12943-022-01575-z
[29]	Zhao L, Zhou X, Xie F, et al. Ferroptosis in cancer and cancer immunotherapy[J]. Cancer Commun (Lond), 2022, 42(2): 88-116. doi: 10.1002/cac2.12250
[30]	Chen X, Kang R, Kroemer G, et al. Broadening horizons: The role of ferroptosis in cancer[J]. Nat Rev Clin Oncol, 2021, 18(5): 280-296. doi: 10.1038/s41571-020-00462-0
[31]	Zhang C, Liu X, Jin S, et al. Ferroptosis in cancer therapy: A novel approach to reversing drug resistance[J]. Mol Cancer, 2022, 21(1): 47. doi: 10.1186/s12943-022-01530-y
[32]	Sun X D, Qin Y, Liu L L, et al. Sodium butyrate inhibits liver cancer cell proliferation by inducing ferroptosis[J]. Journal of Nutrition, 2023, 45(2): 157-162.
[33]	Ao L, Wang D, Shu S H. The study on the inhibitory effect of propofol on the proliferation and migration of liver cancer cells and its mechanism of iron death pathway[J]. Journal of Molecular Diagnosis and Treatment, 2022, 14(12): 2036-2039+2043.
[34]	Zheng Y, Huang C, Lu L, et al. STOML2 potentiates metastasis of hepatocellular carcinoma by promoting PINK1-mediated mitophagy and regulates sensitivity to lenvatinib[J]. J Hematol Oncol, 2021, 14(1): 16. doi: 10.1186/s13045-020-01029-3
[35]	Zhang W, Jiang B P, Liu Y X, et al. Bufotalin induces ferroptosis in non-small cell lung cancer cells by facilitating the ubiquitination and degradation of GPX4[J]. Free Radic Biol Med, 2022, 180: 75-84. doi: 10.1016/j.freeradbiomed.2022.01.009
[36]	Li D B, Wang Y H, Dong C, et al. CST1 inhibits ferroptosis and promotes gastric cancer metastasis by regulating GPX4 protein stability via OTUB1[J]. Oncogene, 2023, 42(2): 83-98. doi: 10.1038/s41388-022-02537-x
[37]	Wang X B, Chen Y Q, Wang X D, et al. Stem cell factor SOX2 confers ferroptosis resistance in lung cancer via upregulation of SLC7A11[J]. Cancer Res, 2021, 81(20): 5217-5229. doi: 10.1158/0008-5472.CAN-21-0567

Relative Articles(20)

Relative Articles

[1]	Zhijie CHENG, Ruijing ZUO, Huanhuan LI, Linxia WU, Minchen KAN, Qianqian WANG. Intervention Mechanism of miR-155 in Macrophage-Derived Exosomes from Sepsis Patients on Endothelial Cell Ferroptosis. Journal of Kunming Medical University, 2026, 47(): 1-10.
[2]	Xiaoxia SHEN, Xiaodong ZHAO, Yongjian SONG. SIRT1 Agonist Treatment of Mice with Coronary Artery Disease Improves Myocardial Function by modulating Nrf2-GPX4 Ferroptosis Pathway. Journal of Kunming Medical University, 2025, 46(5): 55-64. doi: 10.12259/j.issn.2095-610X.S20250507
[3]	Xiaoxia DONG, Shuxian CHEN. Study on the Mechanism by Which GPX4 Expression Promotes Ferroptosis and Participates in Malignant Behavior of Endometrial Carcinoma. Journal of Kunming Medical University, 2025, 46(11): 1-9.
[4]	Chunyu ZHANG, Jian LUO, Qi ZHOU. miR-147a Regulates Ferroptosis and Affects Invasion and Metastasis of Cervical Cancer Cells. Journal of Kunming Medical University, 2025, 46(10): 53-60. doi: 10.12259/j.issn.2095-610X.S20251006
[5]	Ruifeng QIN, Jiadong XUE, Jia ZHANG, Fan LIU, Shaohui ZHANG, Liyang YIN, Zengjiang YUAN. Shikonin Induces Ferroptosis through ROS/JNK Pathway to Intervene in the Malignant Behavior of Pancreatic Cancer. Journal of Kunming Medical University, 2025, 46(10): 44-52. doi: 10.12259/j.issn.2095-610X.S20251005
[6]	Xinyuan XIE, Xiaochen NIU, Jianhui SUN, Yahan ZHANG, Pengfei CHEN. Ferroptosis-Related LncRNAs Signature Predicts the Prognosis of Stomach Adenocarcinoma. Journal of Kunming Medical University, 2025, 46(4): 46-56. doi: 10.12259/j.issn.2095-610X.S20250407
[7]	Maimaitizunong Rezeye, Xiujuan LI, Ling LIU, Hui LI. Effects of Ferroptosis Inhibitor KIF20A on Biological Behavior and Ferroptosis of Esophageal Carcinoma Cells. Journal of Kunming Medical University, 2024, 45(2): 49-56. doi: 10.12259/j.issn.2095-610X.S20240207
[8]	Wei LI, Lihong JIANG, Lijing MA, Rui CHEN, Tongshuo YANG. Research Progress of Iron Death in Cardiomyopathy. Journal of Kunming Medical University, 2024, 45(3): 180-185. doi: 10.12259/j.issn.2095-610X.S20240327
[9]	Zhaosong CHU, Xin WANG, Mengxin HE, Xiufeng XU, Na WANG, Zonglin SHEN. Research Progress on Gene Related to Suicide in Major Depressive Disorder：A Review. Journal of Kunming Medical University, 2023, 44(3): 143-148. doi: 10.12259/j.issn.2095-610X.S20230301
[10]	Dong WANG, Bibo GAO, Huiying SUN, Denghui LENG, Xiaoping RAN, Wen LIN. miR-216b-5p Promotes Ferroptosis in Glioblastoma Cells by Targeting NCOA3. Journal of Kunming Medical University, 2023, 44(8): 44-52. doi: 10.12259/j.issn.2095-610X.S20230805
[11]	Xiaohua LU, Hongxin YUAN. The Analysis of the Correlation between BTLA，CTLA-4 Gene Polymorphisms and the Efficacy and Prognosis of TACE Combined Targeted Therapy for Liver Cancer. Journal of Kunming Medical University, 2023, 44(9): 126-135. doi: 10.12259/j.issn.2095-610X.S20230927
[12]	Xi GUO, Xiaoqing TANG, Jie WANG, Yan WAN, Bin XU, Yu LUO. Effect of Early Interventional Palliative Treatment on Pain and Anxiety in Patients with Hepatitis-Related Liver Cancer. Journal of Kunming Medical University, 2022, 43(8): 93-99. doi: 10.12259/j.issn.2095-610X.S20220813
[13]	Zhu Rong Song , Wei Xiao Ping , Dai Bin , Fan Hai Jun , Tan Yi Zheng , Fan Xue Rong , Tian Da Guang . . Journal of Kunming Medical University, 2019, 40(05): 68-72.
[14]	Liu Xing . Research Advance in the Role of Toll-like Receptors in Hepatocarcinogenesis. Journal of Kunming Medical University,
[15]	Yu Jian . Expressions of Let-7 in Normal Breast Tissue and Breast Cancer Tissue. Journal of Kunming Medical University,
[16]	Guo Tao . . Journal of Kunming Medical University,
[17]	An Xin Huan . . Journal of Kunming Medical University,
[18]	Sun Jian Wei . . Journal of Kunming Medical University,
[19]	Liu Mei . Analysis on Genetic Characteristics of the Nonstructural Protein NSP4 of Human Rotavirus Strains in Infants with Diarrher in 2007 and 2008 in Kunming. Journal of Kunming Medical University,
[20]	Yuan Hui . . Journal of Kunming Medical University,